IDEXX Laboratories, Inc. (IDXX)

IDEXX Laboratories Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	1,027	887.87	845.04	679.09	744.85	581.78
Depreciation & Amortization	140.17	129.94	114.91	111.9	104.6	96
Asset Writedown & Restructuring Costs	-	0.25	1.48	2.35	5.15	2.5
Stock-Based Compensation	58.16	60.3	59.74	49.77	37.76	30.95
Provision & Write-off of Bad Debts	7.77	6.87	5.55	5.83	1.48	4.95
Other Operating Activities	107.78	-22.98	-47.79	-32.42	-0.76	-36.35
Change in Accounts Receivable	-54.78	-28.28	-53.87	-41.4	-33.14	-60.72
Change in Inventory	-5.45	-28	-28.65	-121.73	-52.92	-18.89
Change in Accounts Payable	0.76	8.09	-0.56	3.47	11.23	0.98
Change in Unearned Revenue	2.57	-4.38	-3.03	-11.02	-7.55	-13.37
Change in Other Net Operating Assets	-196.34	-80.67	13.68	-102.85	-55.15	60.24
Operating Cash Flow	1,088	929	906.51	542.98	755.55	648.06
Operating Cash Flow Growth	18.68%	2.48%	66.95%	-28.13%	16.59%	41.14%
Capital Expenditures	-124.5	-120.92	-133.63	-148.84	-119.55	-106.96
Cash Acquisitions	-	-76.69	-	-11.51	-173.42	-1.5
Sale (Purchase) of Intangibles	-23.35	-10	-	-10	-	-0.67
Investment in Securities	-1.76	-1	-	-25	-	-0.25
Other Investing Activities	1.66	1.56	8.38	-	-	-
Investing Cash Flow	-147.95	-207.06	-125.25	-195.35	-292.97	-109.38
Short-Term Debt Issued	-	-	-	505.5	73.5	-
Long-Term Debt Issued	-	-	-	-	-	200
Total Debt Issued	205	-	-	505.5	73.5	200
Short-Term Debt Repaid	-	-	-329	-	-	-
Long-Term Debt Repaid	-	-75	-75	-75	-50	-289.63
Total Debt Repaid	-103.39	-75	-404	-75	-50	-289.63
Net Debt Issued (Repaid)	101.61	-75	-404	430.5	23.5	-89.63
Issuance of Common Stock	88.75	44.49	47.03	35.75	46.57	51.33
Repurchase of Common Stock	-1,232	-847.57	-81.9	-830.32	-762.34	-203.42
Other Financing Activities	-	-	-3.14	-6.87	-5.14	-6.7
Financing Cash Flow	-1,042	-878.07	-442	-370.94	-697.41	-248.42
Foreign Exchange Rate Adjustments	1.46	-9.53	2.13	-8.61	-4.64	3.33
Net Cash Flow	-100.47	-165.67	341.39	-31.91	-239.47	293.6
Free Cash Flow	963.57	808.08	772.88	394.15	636	541.11
Free Cash Flow Growth	21.57%	4.55%	96.09%	-38.03%	17.54%	77.88%
Free Cash Flow Margin	23.12%	20.73%	21.11%	11.71%	19.78%	19.99%
Free Cash Flow Per Share	11.82	9.71	9.20	4.66	7.35	6.24
Cash Interest Paid	33.8	33.8	41	40.3	30.5	32.4
Cash Income Tax Paid	224.2	307.2	192.5	239.8	161.7	110.7
Levered Free Cash Flow	675.23	734.99	693.69	328.16	534.41	436.95
Unlevered Free Cash Flow	698.44	754.49	719.68	353.07	553.04	457.65
Change in Working Capital	-253.23	-133.24	-72.43	-273.53	-137.52	-31.76

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q